-
Trends in GLP-1 Utilization for Diabetes and Obesity in the US: A Retrospective Analysis (2017-2023)
Mar 10, 2025, 14:00 PM -
Analysis of Real-World Evidence Use Across FDA Submissions in 2022 and 2023
Mar 10, 2025, 14:00 PM -
Evidence for the Cumulative Impact of Social Determinants of Health (SDOH) on Cancer Mortality: A Scoping Review
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Axicabtagene Ciloleucel as a Second-Line Treatment for Diffuse Large B-Cell Lymphoma in China
Mar 10, 2025, 14:00 PM -
Advancing Health Equity in Economic Evaluations, With The Distributional Generalized Risk-Adjusted Cost-Effectiveness (DGRACE) Model
Mar 10, 2025, 14:00 PM -
The Use of QALYs in Decision-Making in Europe, Canada, and the US: A Qualitative Review of Methodological Guidance
Mar 10, 2025, 14:00 PM -
Exploring Contemporary Variability in PDMP Budgets and Data Sharing Across the United States
Mar 10, 2025, 14:00 PM -
Mapping the ADDQoL to the EQ-5D-5L and SF-6Dv2 among Chinese Patients with Type 2 Diabetes Mellitus
Mar 10, 2025, 14:00 PM -
China's National Reimbursement Drug List (NRDL) Negotiation: Value Considerations and Key Factors Influencing Payment Standards
Mar 10, 2025, 14:00 PM -
Assessing the Budget Impact and Time Savings of Introducing Nivolumab and Hyaluronidase SC to Patients Receiving Nivolumab IV Across Multiple Indications on a US Healthcare Plan
Mar 10, 2025, 14:00 PM -
A Cost Per Responder Analysis of Ritlecitinib and Baricitinib: Assessing the Impact of Clinical Efficacy and Dosing Variability on Overall Treatment Costs of Severe Alopecia Areata (AA)
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in HER2-Positive Early Breast Cancer in China: A Post-Hoc Analysis of the FeDeriCa Trial
Mar 10, 2025, 14:00 PM -
Advancing the Development of Real-World Data for Cancer Care in China: Challenges and Opportunities
Mar 10, 2025, 14:00 PM -
Time to Access Trends of Pharmaceutical Products in EU4 and UK (2019-2021)
Mar 10, 2025, 14:00 PM -
Assessing Risdiplam Cost-Effectiveness for Spinal Muscular Atrophy Types I, II, and III in Chile
Mar 10, 2025, 14:00 PM -
The Trajectory of Ground Glass Nodule Patients in China: A Real-World Perspective
Mar 10, 2025, 14:00 PM -
How is Patient Safety Addressed in Pharmacy Degree Programs in Brazil?
Mar 10, 2025, 14:00 PM -
Barriers to Genetic Risk Factor Molecular Testing in CLL: An Analysis of Real-World Practice and Alignment with 2023 Guidelines in Germany
Mar 10, 2025, 14:00 PM -
Harnessing Digital Measures of Physical Function in Neurological Conditions: Findings From a Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Comparison of Meaningful Score Difference Estimates From Longitudinal Item Response Theory and Anchor-Based Methods
Mar 10, 2025, 14:00 PM